Genetic polymorphisms in diabetes: Influence on therapy with oral antidiabetics

IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population

(2010) Qiong Huang et al.   ACTA PHARMACOLOGICA SINICA

Effects of the Peroxisome Proliferator Activated Receptor-γ Coactivator-1α(PGC-1α) Thr394ThrandGly482SerPolymorphisms on Rosiglitazone Response in Chinese Patients With Type 2 Diabetes Mellitus

(2010) Ke-Han Zhang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Screening of mutations in the GCK gene in Jordanian maturity-onset diabetes of the young type 2 (MODY2) patients

(2009) R. Khalil et al.   GENETICS AND MOLECULAR RESEARCH

Type 2 diabetes: Where we are today: An overview of disease burden, current treatments, and treatment strategies

(2009) R. Keith Campbell   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes

(2008) M. I. McCarthy et al.   DIABETES

Neonatal Diabetes Mellitus

(2008) Lydia Aguilar-Bryan et al.   ENDOCRINE REVIEWS

Pharmacogenomics and Drug Toxicity

(2008) Yusuke Nakamura   NEW ENGLAND JOURNAL OF MEDICINE

Neonatal and Late-Onset Diabetes Mellitus Caused by Failure of Pancreatic Development: Report of 4 More Cases and a Review of the Literature

(2008) R. Chen et al.   PEDIATRICS

Glucokinase Gene Mutations: Structural and Genotype-Phenotype Analyses in MODY Children from South Italy

(2008) Nadia Tinto et al.   PLoS One

Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

(2008) Rinki Murphy et al.   Nature clinical practice. Endocrinology & metabolism

Chronic Antidiabetic Sulfonylureas In Vivo: Reversible Effects on Mouse Pancreatic β-Cells

(2008) Maria Sara Remedi et al.   PLOS MEDICINE